on Aap Implantate AG (isin : DE0005066609)
BaFin Orders Audit of aap Implantate AG's Financial Statements
aap Implantate AG has announced that BaFin has initiated an audit of the company's consolidated financial statements and management report for 2023. This was disclosed to aap Implantate AG on April 10, 2025. The company is collaborating with BaFin in addressing the audit requirements.
aap aims for a transparent and prompt resolution, seeking a consensual conclusion through constructive dialogue with BaFin. The company's shares trade on the Frankfurt Stock Exchange, and it continues its operations in the medical technology sector.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Aap Implantate AG news